|Student Contribution Band:||Band|
|Administered by:||College of Science and Engineering|
This subject will examine the medicinal chemistry relevant to the process of drug discovery and development as practised in the modern pharmaceutical industry. Building on the material covered in second year, it will develop in students a knowledge of the research tools which are applied in the drug discovery process. Topics in this subject may include: high throughput screening, computational chemistry and molecular modelling, QSAR, combinatorial synthesis techniques, pharmaceutical degradation and the use of natural products or derivatives thereof in pharmaceuticals.
|Prerequisites:||Prerequisites - CH1001, CH1002. Students are also recommended to have completed PC2002 OR CH2043|
|Townsville, Study Period 2, Internal|
|Census Date 29-Aug-2019|
|Coordinator:||Dr Mark Robertson|
|Lecturers:||Assoc. Professor Michael Oelgemoeller, Dr Mark Robertson.|
The student workload for this 3 credit point subject is approximately 130 hours.
|Assessment:||end of semester exam (70%); practicals (30%).|
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.